Nationwide
A Clinical Trial of Sacituzumab Tirumotecan (MK-2870) with Pembrolizumab (MK-3475)
Merck Sharp & Dohme LLC
Ph 3·~6yr·8 sites in FL, LA, NV +4
Enrolling now
Check if I qualifyShowing 1–24 of 65 trials
Merck Sharp & Dohme LLC
Daiichi Sankyo
Sutro Biopharma, Inc.
Merck Sharp & Dohme LLC
GOG Foundation
ModeX Therapeutics, An OPKO Health Company
M.D. Anderson Cancer Center
Medtronic - MITG
Jonsson Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Christian Hinrichs
Bristol-Myers Squibb
Eli Lilly and Company
Tanabe Pharma America, Inc.
Medical College of Wisconsin
Washington University School of Medicine
International Agency for Research on Cancer
Neonc Technologies, Inc.